v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jul. 31, 2026
Jul. 31, 2025
Cash flows from operating activities    
Net income $ 534,365 $ 428,499
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 22,458 19,948
Reduction of lease right-of-use assets 7,038 6,316
Accretion of discount on short-term investments (2,841) (4,535)
Stock-based compensation 256,062 234,176
Amortization of deferred costs 9,805 8,205
Deferred income taxes 26,529 31,699
Other, net (1,127) (1,414)
Changes in operating assets and liabilities:    
Accounts receivable 768,314 593,032
Unbilled accounts receivable (18,361) (9,587)
Deferred costs (7,679) (7,721)
Prepaid expenses and other current and long-term assets (21,394) (21,232)
Accounts payable (652) 3,361
Accrued expenses and other current liabilities (1,578) 23,763
Income tax payable (3,945) (5,362)
Deferred revenue (200,001) (180,888)
Lease liabilities (4,426) (5,300)
Other long-term liabilities 3,258 2,631
Net cash provided by operating activities 1,365,825 1,115,591
Cash flows from investing activities    
Purchases of short-term investments (1,706,632) (1,452,857)
Maturities and sales of short-term investments 1,345,987 1,023,691
Long-term assets (9,773) (12,213)
Acquisitions, net of cash acquired (81,833) 0
Net cash used in investing activities (452,251) (441,379)
Cash flows from financing activities    
Proceeds from exercise of common stock options 17,143 182,297
Repurchases of common stock (472,673) 0
Taxes paid related to net share settlement of equity awards (66,304) (46,228)
Net cash (used in) provided by financing activities (521,834) 136,069
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (831) 1,365
Net change in cash, cash equivalents, and restricted cash 390,909 811,646
Cash, cash equivalents, and restricted cash at beginning of period 1,423,412 1,120,963
Cash, cash equivalents, and restricted cash at end of period 1,814,321 1,932,609
Cash, cash equivalents, and restricted cash at end of period:    
Cash and cash equivalents 1,812,012 1,930,431
Restricted cash included in other long-term assets 2,309 2,178
Total cash, cash equivalents, and restricted cash at end of period 1,814,321 1,932,609
Supplemental disclosures of other cash flow information:    
Cash paid for income taxes, net of refunds 151,543 126,683
Excess tax (deficiency) benefit from employee stock plans $ (824) $ 15,610